Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 40 record(s)

Req # A-2022-09622

All correspondence and emails from the federal Health Minister Jean-Yves Duclos to the Patented Medicines Prices Review Board in the period between October 1, 2022 and December 5, 2022 regarding new draft guidelines and the consultation process and all responses to the federal Minister of Health and Health Canada from the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier.

Organization: Patented Medicine Prices Review Board Canada

9 page(s)
February 2023

Req # A-2020-00050

Data, research, reports and studies obtained from the Council of Canadian Academies report entitled Turning Point: The Expert Panel on the Circular Economy in Canada

Organization: Social Sciences and Humanities Research Council of Canada

0 page(s)
February 2023

Req # A-2020-18439

Copies of all email exchanges between the PMPRB and pCPA and CADTH members in the provincial offices from June 1, 2019 to November 19, 2020.

Organization: Patented Medicine Prices Review Board Canada

693 page(s)
February 2022

Req # A-2021-10646

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Boehringer Ingelheim over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.

Organization: Patented Medicine Prices Review Board Canada

50 page(s)
February 2022

Req # A-2021-10666

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Sanofi Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
February 2022

Nothing to report this month

Organization: Defence Construction Canada

February 2022

Req # A-2020-00811

Provide the specific dollar penalties and total claimed by the PMPRB from the use of excessive prices penalty since 2005 and documentation showing what the money was used for.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
February 2021

Req # A-2020-00813

Copies of documents related to the use of the excessive price penalty against Alexion Pharmaceuticals.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
February 2021

Req # A-2020-14747

Copies of meeting minutes, presentations and speaking notes associated with rare disease drugs from May 1, 2020 to July 31, 2020.

Organization: Patented Medicine Prices Review Board Canada

654 page(s)
February 2021

Req # A-2020-18436

Provide a detailed disclosure of all third parties consultations over regulation and pricing of new drugs from June 1, 2019 to November 19, 2020, broken down by date, meeting minutes, and summary of meetings.

Organization: Patented Medicine Prices Review Board Canada

474 page(s)
February 2021
Date modified: